US Patent Issued to GI INNOVATION on July 28 for "Pharmaceutical composition for treatment of cancer, comprising an immune checkpoint inhibitor antibody and a fusion protein comprising an IL-2 mutant and a CD80 extracellular domain" (South Korean Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,307, issued on July 28, was assigned to GI INNOVATION INC. (Seoul, South Korea).

"Pharmaceutical composition for treatment of cancer, comprising an immune checkpoint inhibitor antibody and a fusion protein comprising an IL-2 mutant and a CD80 extracellular domain" was invented by Myoung Ho Jang (Seoul, South Korea), Su Youn Nam (Seoul, South Korea), Young Jun Koh (Seoul, South Korea) and Young-Gyu Cho (Daejeon, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "A pharmaceutical composition containing, as active ingredients, a fusion protein dimer including an IL-2 protein or a variant thereof and a CD80 protein or a fragment thereof, and an ...